A pilot study in patients with established advanced liver fibrosis using pirfenidone

被引：73
作者：
Armendariz-Borunda, J.
Islas-Carbajal, M. C.
Meza-Garcia, E.
Rincon, A. R.
Lucano, S.
Sandoval, A. S.
Salazar, A.
Berumen, J.
Alvarez, A.
Covarrubias, A.
Arechiga, G.
Garcia, L.
机构：
[1] Univ Guadalajara, Inst Mol Biol Med & Gene Therapy, Guadalajara, Jalisco, Mexico
[2] OPD Civil Hosp Guadalajara, Guadalajara, Jalisco, Mexico
[3] Inst Chron Degenerat Dis, Guadalajara, Jalisco, Mexico
来源：
GUT | 2006年 / 55卷 / 11期
关键词：
D O I：
10.1136/gut.2006.107136
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1663 / 1665
页数：3
相关论文
共 6 条
  • [1] Armendariz-Borunda J, 2003, HEPATOLOGY, V38, p308A
  • [2] Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy
    Bonkovsky, HL
    Woolley, JM
    [J]. HEPATOLOGY, 1999, 29 (01) : 264 - 270
  • [3] The anti-fibrotic effect of pirfenidone in rat liver fibrosis is mediated by downregulation of procollagen α1(I), TIMP-1 and MMP-2
    Di Sario, A
    Bendia, E
    Macarri, G
    Candelaresi, C
    Taffetani, S
    Marzioni, M
    Omenetti, A
    De Minicis, S
    Trozzi, L
    Benedetti, A
    [J]. DIGESTIVE AND LIVER DISEASE, 2004, 36 (11) : 744 - 751
  • [4] Pirfenidone effectively reverses experimental liver fibrosis
    García, L
    Hernández, I
    Sandoval, A
    Salazar, A
    Garcia, J
    Vera, J
    Grijalva, G
    Muriel, P
    Margolin, S
    Armendariz-Borunda, J
    [J]. JOURNAL OF HEPATOLOGY, 2002, 37 (06) : 797 - 805
  • [5] Induction of collagen type I in hepatic stellate cells cocultured with Hep-G2 cells overexpressing CYP2E1.
    Nieto, N
    Friedman, SL
    Greenwel, P
    Schuppan, D
    Cederbaum, AI
    [J]. HEPATOLOGY, 2000, 32 (04) : 185A - 185A
  • [6] Fibrosis in chronic liver diseases: diagnosis and management
    Pinzani, M
    Rombouts, K
    Colagrande, S
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 : S22 - S36
1